MC1R-targeted Alpha-particle Therapy Trial in Adults With Advanced Melanoma
Conditions: Melanoma (Skin); Metastatic Melanoma; Melanoma Stage IV; Melanoma, Uveal; Mucosal Melanoma; Melanoma Stage III Intervention: Drug: [212Pb]VMT01 Sponsor: Viewpoint Molecular Targeting Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials